Independence Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Independence Trust's ABBV Position: Q4 2017 in Review
Independence Trust increased its AbbVie (ABBV) stake by 0.23% in Q4 2017, buying an estimated $5.66K and bringing the position to 26,193 shares worth $2.53M. The position accounts for 2.8% of the portfolio, ranked #14.
Independence Trust first reported a position in ABBV in Q2 2013 and has held it in 19 quarters since. 2,000 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.
- Independence Trust held 26,193 shares of AbbVie worth $2.53M as of Q4 2017.
- Independence Trust bought 60 AbbVie shares in Q4 2017, an estimated $5.66K.
- AbbVie made up 2.8% of Independence Trust's portfolio in Q4 2017, its #14 holding.
- Independence Trust first reported a position in AbbVie in Q2 2013 and has held it in 19 quarters since.
- 2,000 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.
Based on Independence Trust's 13F filing for Q4 2017, filed 8 Feb 2018.